Loading...

Star Equity Holdings, Inc.

STRRNASDAQ
Healthcare
Medical - Diagnostics & Research
$2.13
$0.00(0.00%)

Star Equity Holdings, Inc. (STRR) Financial Performance & Income Statement Overview

Analyze Star Equity Holdings, Inc. (STRR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
16.54%
16.54%
Operating Income Growth
-93.63%
93.63%
Net Income Growth
-141.53%
141.53%
Operating Cash Flow Growth
-292.03%
292.03%
Operating Margin
-8.22%
8.22%
Gross Margin
24.71%
24.71%
Net Profit Margin
-3.19%
3.19%
ROE
-3.66%
3.66%
ROIC
-7.00%
7.00%

Star Equity Holdings, Inc. (STRR) Income Statement & Financial Overview

Analyze Star Equity Holdings, Inc.’s STRR earnings with segmented quarterly and yearly financial statement figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$17.09M$13.66M$13.48M$9.12M
Cost of Revenue$12.65M$10.85M$11.27M$7.99M
Gross Profit$4.45M$2.82M$2.22M$1.13M
Gross Profit Ratio$0.26$0.21$0.16$0.12
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$143000.00$7.42M$5.34M$4.09M
Operating Expenses$866000.00$8.14M$5.34M$4.09M
Total Costs & Expenses$13.51M$18.98M$16.61M$12.08M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$374000.00
Depreciation & Amortization$1.08M$1.03M$795000.00$688000.00
EBITDA$4.67M-$4.29M-$2.92M-$2.27M
EBITDA Ratio$0.27-$0.31-$0.22-$0.25
Operating Income$3.58M-$5.32M-$3.12M-$2.97M
Operating Income Ratio$0.21-$0.39-$0.23-$0.33
Other Income/Expenses (Net)-$5.75M$3.33M-$703000.00$773000.00
Income Before Tax-$2.17M-$1.99M-$3.83M-$2.19M
Income Before Tax Ratio-$0.13-$0.15-$0.28-$0.24
Income Tax Expense$285000.00-$18000.00-$39000.00$35000.00
Net Income-$2.46M-$1.97M-$3.79M-$2.22M
Net Income Ratio-$0.14-$0.14-$0.28-$0.24
EPS-$0.95-$0.78-$1.34-$0.14
Diluted EPS-$0.95-$0.78-$1.34-$0.14
Weighted Avg Shares Outstanding$3.20M$3.21M$3.17M$15.84M
Weighted Avg Shares Outstanding (Diluted)$3.20M$3.21M$3.17M$15.84M

Over the last four quarters, Star Equity Holdings, Inc. achieved steady financial progress, growing revenue from $9.12M in Q1 2024 to $17.09M in Q4 2024. Gross profit stayed firm with margins at 26% in Q4 2024 versus 12% in Q1 2024. Operating income totaled $3.58M in Q4 2024, maintaining a 21% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $4.67M. Net income dropped to -$2.46M, with EPS at -$0.95. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;